Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies

por Li, Qingrong, Ma, Qiang, Cheng, Jibing, Zhou, Xi, Pu, Wenjie, Zhong, Xiaowu, Guo, Xiaolan
Publicado 2021

Comprehensive Analysis of Potential Correlation Between Solute Carrier 1A (SLC1A) Family and Lung Adenocarcinoma

por Zhong, Xiaowu, Yao, Lihua, Xu, Lei, Ma, Qiang, Huang, Guangcheng, Yang, Miyuan, Gao, Chuanli, Cheng, Jibing, Zhou, Xi, Li, Qinrong, Guo, Xiaolan
Publicado 2022

Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer

por Li, Qingrong, Ma, Qiang, Xu, Lei, Gao, Chuanli, Yao, Lihua, Wen, Jilin, Yang, Miyuan, Cheng, Jibing, Zhou, Xi, Zou, Jiang, Zhong, Xiaowu, Guo, Xiaolan
Publicado 2021

Autophagy-dependent cell cycle arrest in esophageal cancer cells exposed to dihydroartemisinin

por Ma, Qiang, Liao, Hebin, Xu, Lei, Li, Qingrong, Zou, Jiang, Sun, Ru, Xiao, Dan, Liu, Chang, Pu, Wenjie, Cheng, Jibing, Zhou, Xi, Huang, Guangcheng, Yao, Lihua, Zhong, Xiaowu, Guo, Xiaolan
Publicado 2020